相似文献
1
Malignant pleural effusion.
Thorax. 1995 Jan;50(1):103-4. doi: 10.1136/thx.50.1.103-b.
2
Counterpoint: should thoracoscopic talc pleurodesis be the first choice management for malignant pleural effusion? No.
Chest. 2012 Jul;142(1):17-19. doi: 10.1378/chest.12-1087.
3
Cost-effective pleurodesis.
Chest. 1998 Jun;113(6):1731-2. doi: 10.1378/chest.113.6.1731-b.
4
[Talc--a standard drug in the treatment of malignant pleural effusion].
Cas Lek Cesk. 1999 Jan 25;138(3):82-4.
5
Talc pleurodesis for treating malignant pleural effusions.
Chest. 1995 Oct;108(4):1178-9. doi: 10.1378/chest.108.4.1178-b.
6
Talc pleurodesis in pleuropulmonary diseases treatment.
Med Glas (Zenica). 2014 Aug;11(2):264-9.
7
[Talc pleurodesis in recurrent malignant pleural effusion--a prospective follow-up study].
Zentralbl Chir. 1996;121(3):216-22.
8
[Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
Beijing Da Xue Xue Bao Yi Xue Ban. 2008 Dec 18;40(6):600-2.
9
Point: Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes.
Chest. 2012 Jul;142(1):15-17. doi: 10.1378/chest.12-1085.
10
Management of recurrent malignant pleural effusion with chemical pleurodesis.
Surg Today. 2005;35(8):634-8. doi: 10.1007/s00595-005-2996-5.
本文引用的文献
1
Management of malignant pleural effusion.
Thorax. 1993 Aug;48(8):779-80. doi: 10.1136/thx.48.8.779.
2
Thoracoscopic talc poudrage pleurodesis for chronic recurrent pleural effusions.
Ann Intern Med. 1991 Nov 15;115(10):778-82. doi: 10.7326/0003-4819-115-10-778.
3
Early and late outcome after diagnostic thoracoscopy and talc pleurodesis.
Ann Thorac Surg. 1992 Jun;53(6):1038-41. doi: 10.1016/0003-4975(92)90384-g.
Zotero 插件